Marc Froissart is currently professor of clinical research at the University Hospital of Lausanne (CHUV-UNIL), Switzerland. There he recently built the Clinical Research Center, a transversal facility providing support to the research community within the Swiss Clinical Trial Organization overarching network.

Marc currently coordinates the nephrology and transplantation research team in Lausanne. As a nephrologist, nuclear medicine specialist and epidemiologist by training, he naturally focused his early research interests on measuring GFR and assessing CKD through cohort studies. Marc then joined Amgen European headquarters in Switzerland acting as clinical research medical director before returning to academia in Lausanne.

His clinical research activities covered observational studies (NephroTest ND-CKD cohort, ARO initiative HD cohort), participation to research consortia (CKD-EPI, CKD-PC) and interventional trials either acting as investigator or sponsor medical lead.